metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Effect of the combination of orlistat and l-carnitine on the quality of life (sf...
Journal Information
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(February 2024)
Full text access
Effect of the combination of orlistat and l-carnitine on the quality of life (sf-36) in 16 overweigth patients. a preliminary result
Visits
1437
Saúl A. Vera-Nungaray1, Miguel Y. Carmona-Castillo1, María F. Higuera-de la Tijera1, Livan Delgado-Roche2, Evelyn Altamirano-Castillo3, Nancy G. Vega-López4, Uriel Gutiérrez-Estrada4, Santiago Camacho-Hernández1
1 Gastroenterology Service, General Hospital of Mexico, Mexico City, Mexico
2 Clinical Research Manager, Liomont Laboratories, Mexico City, Mexico City, Mexico
3 General Hospital Of Zone 8, Mexican Social Security Institute, Mexico City, Mexico
4 National Polytechnic Institute, Mexico City, Mexico
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Special issue
This article is part of special issue:
Vol. 29. Issue S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

More info
Introduction and Objectives

Orlistat is a drug widely used in overweight/obese patients, while the combination with l-carnitine could offer an improvement in its effectiveness. To our knowledge, the effect of this combination on the quality of life of overweight patients has not been determined.

To evaluate the effects on the quality of life of patients who took the combination of orlistat and l-carnitine at 4 and 8 weeks of treatment.

Materials and Patients

: We evaluated the quality of life (Short Form-36) in 16 patients [41.81±8.26 (37.77-45.86) years, 81% women] undergoing pharmacotherapy of the combination of orlistat and l-carnitine (once a day) at 4 and 8 weeks of treatment. Data express mean±SD and 95%IC or percentages as correspond. We use paired Student t Test, two tails with an alpha=0.05.

Results

Patients lowered their weight by about 3%. Patients show improvement in body pain, general health, vitality and in both Mental [45.68±6.51 (42.49-48.86) vs. 49.88±3.21 (48.31-51.46), p=0.02] and Physical [59.4±8.92 (55.03-63.77) vs. 63.36±9.64 (58.63-68.08), p=0.01) summaries.

Conclusions

These results suggest a beneficial effect of the combination of Orlistat and l-carnitine on the treatment of overweight. Further studies compared with placebo and standard care are required.

Full Text

Ethical statement

The protocol was approved by the local research and ethical committees.

Registration number: DECS/JPO-CT-1944-2023.

Declaration of interests

None

Funding

Laboratorios Liomont provided the medicament “orlistat and l-carnitine” for this study.

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2024.101436
No mostrar más